Literature DB >> 6991628

Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection.

P Potocnjak, N Yoshida, R S Nussenzweig, V Nussenzweig.   

Abstract

Monoclonal antibodies (IG1, k) directed against a surface component of Plasmodium berghei sporozoites (Pb-44) confer complete protection to mice against a lethal inoculum of parasites. The degree of protection is a function of the number of parasites used in the challenge and of the antibody concentration in serum. Passive transfer of 10 micrograms of antibody per mouse abolished or profoundly diminished the infectivity of 10(3) sporozoites, but much higher amounts of antibody were required for complete protection against challenge with 10(4) parasites. Fab fragments of the monoclonal antibodies were as effective as the intact antibodies in mediating protection as determined by the neutralizing assay. This observation suggests that the antibodies interfere with a parasite function necessary for its infectivity, such as, for example, the ability to penetrate into the target cell or to multiply in the hepatocytes. When sporozoites are incubated with the intact monoclonal antibodies at 37 degrees C, a long filament appears at its posterior end (circumsporzoite precipitation [CSP] reaction). Fab fragments are ineffective at high concentrations. However, if after treatment with Fab, the sporozoites are incubated with rabbit antibodies to mouse k-chains, a strong CSP reaction is observed. We conclude that the CSP reaction can result from the cross-linking of Pb44 and that it has the characteristics of a capping reaction followed by the shedding of the immune complexes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6991628      PMCID: PMC2185881          DOI: 10.1084/jem.151.6.1504

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

3.  Plasmodium berghei: relationship between protective immunity and anti-sporozoite (CSP) antibody in mice.

Authors:  G L Spitalny; R S Nussenzweig
Journal:  Exp Parasitol       Date:  1973-02       Impact factor: 2.011

4.  Further studies on the Plasmodium berghei-Anopheles stephensi--rodent system of mammalian malaria.

Authors:  J P Vanderberg; R S Nussenzweig; H Most
Journal:  J Parasitol       Date:  1968-10       Impact factor: 1.276

5.  Studies on anti-leishmania activity of immune rabbit serum.

Authors:  H R Rezai; N Behforouz; S Gettner
Journal:  J Parasitol       Date:  1970-04       Impact factor: 1.276

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. V. In vitro effects of immune serum on sporozoites.

Authors:  J Vanderberg; R Nussenzweig; H Most
Journal:  Mil Med       Date:  1969-09       Impact factor: 1.437

8.  Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. IV. Dose response, specificity and humoral immunity.

Authors:  R Nussenzweig; J Vanderberg; H Most
Journal:  Mil Med       Date:  1969-09       Impact factor: 1.437

9.  Antibody-induced ultrastructural changes of malarial sporozoites.

Authors:  A H Cochrane; M Aikawa; M Jeng; R S Nussenzweig
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

10.  Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites.

Authors:  D F Clyde
Journal:  Am J Trop Med Hyg       Date:  1975-05       Impact factor: 2.345

View more
  141 in total

Review 1.  Anti-sporozoite antibodies.

Authors:  M R Hollingdale
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  Genetic restriction of protective immunity to Plasmodium yoelii sporozoites.

Authors:  W R Weiss; M F Good; M R Hollingdale; L H Miller; J A Berzofsky
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

3.  Antibodies to Plasmodium circumsporozoite protein (CSP) inhibit sporozoite's cell traversal activity.

Authors:  Satish Mishra; Ruth S Nussenzweig; Victor Nussenzweig
Journal:  J Immunol Methods       Date:  2012-01-28       Impact factor: 2.303

4.  Monoclonal antibodies produced against sporozoites of the human parasite Plasmodium malariae abolish infectivity of sporozoites of the simian parasite Plasmodium brasilianum.

Authors:  A H Cochrane; J W Barnwell; W E Collins; R S Nussenzweig
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

Review 5.  Malaria: immunity and prospects for vaccination.

Authors:  M Hommel
Journal:  West J Med       Date:  1981-10

6.  Monoclonal antibody identifies circumsporozoite protein of Plasmodium malariae and detects a common epitope on Plasmodium brasilianum sporozoites.

Authors:  A H Cochrane; W E Collins; R S Nussenzweig
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

7.  Protective humoral immunity elicited by a needle-free malaria vaccine comprised of a chimeric Plasmodium falciparum circumsporozoite protein and a Toll-like receptor 5 agonist, flagellin.

Authors:  Daniel Carapau; Robert Mitchell; Adéla Nacer; Alan Shaw; Caroline Othoro; Ute Frevert; Elizabeth Nardin
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

8.  Monoclonal antibodies identify the protective antigens of sporozoites of Plasmodium knowlesi.

Authors:  A H Cochrane; F Santoro; V Nussenzweig; R W Gwadz; R S Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

9.  A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of Hep-G2 cells and protect immunized mice against P. berghei sporozoite challenge.

Authors:  S Chatterjee; M Wery; P Sharma; V S Chauhan
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

10.  Role of macrophages in malaria: O2 metabolite production and phagocytosis by splenic macrophages during lethal Plasmodium berghei and self-limiting Plasmodium yoelii infection in mice.

Authors:  V Brinkmann; S H Kaufmann; M M Simon; H Fischer
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.